Literature DB >> 32114209

Suicidal behavior in treatment resistant major depressive disorder patients treated with transmagnetic stimulation(TMS) and its relationship with cognitive functions.

Selma Ozcan1, Sakir Gica2, Huseyin Gulec3.   

Abstract

The aim of this study is to investigate the effects of rTMS treatment on suicidal thoughts/behaviors and to determine the cognitive mechanisms underlying the effects of rTMS treatment on suicidal thoughts/behaviors in treatment-resistant depression(TRD). Thirty patients with TRD received rTMS 5 sessions per week for 4-6 weeks. Montgomery-Asberg Depression Rating Scale(MADRS), Columbia Suicide Severity Rating Scale(C-SSRS), Suicidal Ideation Scale(SIS), Beck Hopelessness Scale(BHS) and Cambridge Neuropsychological Test Automated Battery(CANTAB) were administered before and after treatment. After rTMS treatment, there was a significant decrease in depressive complaints and suicidal thoughts and improvement in emotional recognition. However, there was no significant change in cognitive functions such as cognitive flexibility, motor response inhibition and decision making. Pre-treatment decision-making and flexible thinking skills were related to the change in suicidal ideation. In TRD patients, rTMS has a positive effect on depressive symptoms and suicidal thoughts/behaviors and emotion recognition abilities. Although there is no negative effect on other cognitive functions, the positive effect of rTMS on cognitive functions is limited. At this point, we think that the TRD would be treated more effectively with treatments targeting specific symptom clusters such as other cognitive functions and suicidal thoughts.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cognitive flexibility; Decision-making; Emotion recognition; Response ınhibition; Suicide; Transcranial magnetic stimulation; Treatment resistant depression

Year:  2020        PMID: 32114209     DOI: 10.1016/j.psychres.2020.112873

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  2 in total

1.  Association of Chemokine (C-C Motif) Receptor 5 and Ligand 5 with Recovery from Major Depressive Disorder and Related Neurocognitive Impairment.

Authors:  Olivia Bauer; Vladimir M Milenkovic; Sven Hilbert; Nina Sarubin; Johannes Weigl; Lisa-Marie Bahr; Thomas C Wetter; Barbara Heckel; Christian H Wetzel; Rainer Rupprecht; Caroline Nothdurfter
Journal:  Neuroimmunomodulation       Date:  2021-01-27       Impact factor: 2.492

2.  Influence of theta-burst transcranial magnetic stimulation over the dorsolateral prefrontal cortex on emotion processing in healthy volunteers.

Authors:  Ana Dumitru; Lorenzo Rocchi; Fedal Saini; John C Rothwell; Jonathan P Roiser; Anthony S David; Raphaelle M Richieri; Gemma Lewis; Glyn Lewis
Journal:  Cogn Affect Behav Neurosci       Date:  2020-09-30       Impact factor: 3.282

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.